[Federal Register Volume 87, Number 217 (Thursday, November 10, 2022)]
[Notices]
[Pages 67920-67921]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24610]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Charter Renewal of the Advisory Committee on Blood and Tissue 
Safety and Availability

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services is hereby giving 
notice that the charter for the Advisory Committee on Blood and Tissue 
Safety and Availability (ACBTSA) has been renewed.

FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal 
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS 
Policy, Office of the Assistant Secretary for Health, Department of 
Health and Human Services, Tower Building, 1101 Wootton Parkway, 
Rockville, MD 20852. Phone: (202) 795-7608. Email: [email protected].

SUPPLEMENTARY INFORMATION: The ACBTSA is a non-discretionary federal 
advisory committee. The ACBTSA is authorized under 42 U.S.C. 217a, 
Section 222 of the Public Health Service (PHS) Act, as amended. The 
Committee is governed by the provisions of the Federal Advisory 
Committee Act (FACA), Public Law 92-463, as amended (5 U.S.C. App), 
which sets forth standards for the formation and use of advisory 
committees. The ACBTSA advises, assists, consults with, and makes 
policy recommendations to the Secretary, through the Assistant 
Secretary for Health, regarding broad responsibilities related to the 
safety of blood, blood products, tissues, and organs. For solid organs 
and blood stem cells, the Committee's work is limited to policy issues 
related to donor derived

[[Page 67921]]

infectious disease complications of transplantation.
    To carry out its mission, the ACBTSA provides advice to the 
Secretary through the Assistant Secretary for Health on a range of 
policy issues which includes: (1) identification of public health 
issues through surveillance of blood and tissue safety issues with 
national biovigilance data tools; (2) identification of public health 
issues that affect availability of blood, blood products, and tissues; 
(3) broad public health, ethical, and legal issues related to the 
safety of blood, blood products, and tissues; (4) the impact of various 
economic factors (e.g., product cost and supply) on safety and 
availability of blood, blood products, and tissues; (5) risk 
communications related to blood transfusion and tissue transplantation; 
and (6) identification of infectious disease transmission issues for 
blood, organs, blood stem cells and tissues.
    On September 29, 2022, the Secretary approved for the ACBTSA 
charter to be renewed. The new charter was filed with the appropriate 
Congressional committees and the Library of Congress on October 9, 
2022. Renewal of the Committee's charter gives authorization for the 
Committee to continue to operate until October 9, 2024.
    A copy of the ACBTSA charter is available on the Committee's 
website at https://www.hhs.gov/oidp/advisory-committee/blood-tissue-safety-availability/charter/index.html.

    Dated: November 2, 2022.
James J. Berger,
DFO, Advisory Committee on Blood and Safety and Availability, Office of 
HIV/AIDS and Infectious Disease Policy.
[FR Doc. 2022-24610 Filed 11-9-22; 8:45 am]
BILLING CODE 4150-41-P